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SUMMARY. The purpose of this work is to explore the potential of combining poloxamer 407 and car-
rageenan for its utilization in an injectable depot drug release system. Reverse thermal gelation of these
formulations allow the local injection in liquid form, gelling in situ after its administration. Carrageenan
reinforces the structure of poloxamer gels (after 50 h of testing only 20 % of the system is eroding) and al-
lows to modulate the release rate of progesterone as a function of formulations composition. The elastic
modulus of sole poloxamer gels (G’ = 56 Pa) increases significantly in presence of carrageenan (G’ = 1 347
Pa) at 10 °C. The gelation temperature of tested formulations is between 17 and 22 °C and the gelation
process is very quick. Poloxamer-carrageenan systems offer a promissory alternative approach to develop-
ment of injectable depot systems for veterinary use.
